Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSecure Trust Bank Regulatory News (STB)

Share Price Information for Secure Trust Bank (STB)

Share Price is delayed by 15 minutes
Get Live Data
1,276.00    6.00 (0.47%)
Bid:
1,280.00
Ask:
1,306.00
Spread: 26.00 (2.031%)
Market Cap: £239.05m
STB Live PriceLast checked at - London Stock Exchange

Intraday Secure Trust Bank Share Chart

Pre-Close Statement

10 Jan 2012 07:01

RNS Number : 2559V
Arbuthnot Banking Group PLC
10 January 2012
 



 

For Immediate Release

 

PRESS RELEASE 10 January 2012

 

 

 

 ARBUTHNOT BANKING GROUP PLC

 

 

PRE-CLOSE STATEMENT

 

 

Overall 2011 has been a successful year for Arbuthnot Banking Group PLC ("ABG" or the "Group"). The economic and business environment remained difficult in 2011 but ABG has taken some major steps, creating significant value for shareholders and positioning the Group to enable it to take advantage of the opportunities that are currently available.

 

The two most important events during the year were the IPO of Secure Trust Bank PLC ("STB") and the sale of Arbuthnot Securities Limited ("ASL").

 

The Group's capital position has been further strengthened by the IPO of STB. Arbuthnot Latham and STB remain highly liquid and both banks are continuing to grow their balance sheet and fee income.

 

The sale of ASL requires regulatory approval before it can be completed and this was not received before the year end. The results will therefore, include approximately £8 million trading losses for the year and £3.5 million of provisions in respect of the costs of an employee share scheme but will exclude the final loss on sale which is expected to be approximately £1 million. ASL's results for the year will be reported as discontinued operations.

 

STB continues to work on significant organic and external business opportunities. However, in respect of the consumer finance joint venture previously mentioned by ABG, despite exhaustive efforts we have been unable to agree a structure which meets the regulatory requirements and falls within our risk appetite; consequently the joint venture will not be proceeding as expected. As a result anticipated income associated with the joint venture has not been received and some extra costs associated with carrying excess deposits have been incurred. 

 

Accordingly, ABG expects profits before tax in 2011 for the continuing operations to be around £5.0 million. In addition ABG expects to record in its profit and loss reserves a gain on the sale of the shares in STB of approximately £16.5 million.

 

STB is also making a pre close statement today which should be read in conjunction with this statement.

 

Enquiries:

 

Arbuthnot Banking Group PLC Tel: 020 7012 2400

Henry Angest, Chairman and Chief Executive

Andrew Salmon, Chief Operating Officer

James Cobb, Group Finance Director

David Marshall, Director of Communications

 

Hawkpoint Partners Limited (Nominated Adviser) Tel: 020 7665 4500

Lawrence Guthrie

 

Numis Securities Limited Tel: 020 7260 1000

Christopher Wilkinson

Mark Lander

 

Pelham Bell Pottinger Tel: 020 7861 3232

Ben Woodford

Dan de Belder

 

 

Notes to editors:

Arbuthnot Banking Group consists of three main subsidiaries providing banking services to a wide cross-section of clients.

 

Arbuthnot Latham is the private banking and wealth management arm of the group. It provides banking, financial planning and investment management services to clients.

 

The group also has a full-service, integrated investment bank, Arbuthnot Securities, which offers a full range of institutional stockbroking and corporate advisory services and is focused on UK growth companies.

 

The retail banking arm of the group is Secure Trust Bank. Secure Trust Bank provides a wide scope of services to customers including personal loans, current and savings accounts and financial advice.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBIGDBIGGBGDC
Date   Source Headline
7th Jul 20253:51 pmRNSDirector/PDMR Shareholding
4th Jul 20251:59 pmRNSDirector/PDMR Shareholding
2nd Jul 20257:00 amRNSStrategic pivot to increase Group ROAE
1st Jul 20253:34 pmRNSTotal Voting Rights
17th Jun 20257:00 amRNSCEO Succession Plan
16th Jun 20253:00 pmRNSDirector/PDMR Shareholding
12th Jun 20257:30 amRNSNon-Executive Director Appointment
30th May 20254:02 pmRNSTotal Voting Rights
15th May 20254:58 pmRNSResult of 2025 AGM
15th May 20257:00 amRNSQ1 2025 Trading Update
25th Apr 20255:50 pmRNSDirector/PDMR Shareholding
24th Apr 202511:43 amRNSDirector/PDMR Shareholding
17th Apr 20258:30 amRNSDirector/PDMR Shareholding
8th Apr 20254:43 pmRNSDirector/PDMR Shareholding
4th Apr 202511:20 amRNSNotice of AGM
26th Mar 20253:01 pmRNSDirector/PDMR Shareholding
24th Mar 20254:48 pmRNSDirector/PDMR Shareholding
24th Mar 20254:47 pmRNSDirector/PDMR Shareholding
17th Mar 20252:48 pmRNSDirector/PDMR Shareholding
13th Mar 20253:56 pmRNSAnnual Financial Report
13th Mar 20257:00 amRNSFinal Results
11th Mar 20259:00 amRNSNotice of Retail Investor Webcast
14th Feb 20252:11 pmRNSHolding(s) in Company
7th Feb 202511:59 amRNSHolding(s) in Company
7th Feb 202511:38 amRNSHolding(s) in Company
3rd Feb 20251:34 pmRNSBlock listing Interim Review
16th Jan 202511:07 amRNSHolding(s) in Company
24th Dec 202411:18 amRNSHolding(s) in Company
23rd Dec 20242:36 pmRNSHolding(s) in Company
19th Dec 20244:28 pmRNSDirector Declaration
18th Dec 202411:44 amRNSHolding(s) in Company
13th Dec 20243:14 pmRNSAppointment of Remuneration Committee Chairman
6th Dec 20245:07 pmRNSHolding(s) in Company
2nd Dec 20241:47 pmRNSDirector/PDMR Shareholding
19th Nov 20244:19 pmRNSHolding(s) in Company
13th Nov 20244:50 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSCapital Markets Event
8th Nov 20241:15 pmRNSHolding(s) in Company
1st Nov 20243:51 pmRNSHolding(s) in Company
1st Nov 20243:15 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTrading Update
28th Oct 202412:14 pmRNSVehicle Finance Update
24th Oct 20247:30 amRNSNon-Executive Director Succession
16th Oct 20248:54 amRNSNotice of Capital Markets Event and Q3 Update
10th Oct 20244:37 pmRNSHolding(s) in Company
27th Sep 20243:37 pmRNSDirector/PDMR Shareholding
16th Sep 202411:31 amRNSDirector/PDMR Shareholding
2nd Sep 20248:30 amRNSTotal Voting Rights
21st Aug 20242:01 pmRNSDirector/PDMR Shareholding
19th Aug 202410:29 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.